International Trade committee  I'm sorry, Ben; that was just a PR exercise. The reality is that Moderna and all mRNA manufacturers understand that in the mRNA space, there's actually very little IP. It's a trade secret. You can share your IP. You can share the sequence of your mRNA, but it's a trade secret w

International Trade committee  My understanding is that they really can't do anything internationally. That's why Manitoba approached us, and we'll be signing a definitive agreement with them this week. We've also had some discussion with Ontario. That discussion is sort of on pause right now. They have their

International Trade committee  Our phase I trial is complete. The last follow-up visit for our subject is tomorrow. We will then lock all the data. Our CRO that's supporting us will complete the report. That report should be available within four or five weeks.

International Trade committee  That is correct.

International Trade committee  We need phase II and phase III in order to receive emergency use authorization. We went to Health Canada seeking a combined phase II-phase III trial, and Health Canada felt that it would be more appropriate for us to split those trials into discrete trials. That has the effect of

International Trade committee  That is correct. If we wait until approval to start manufacturing, given the lead times for manufacturing, we need to start now if we want to have doses ready when approval is obtained.

International Trade committee  Thank you, Ziad. So far the government has worked rather effectively when it comes to clinical trials. We've received support from the NRC. We're in phase II with the NRC. We've submitted our application to the strategic innovation fund for phase III. I do have confidence that

International Trade committee  Well, phase I was announced last year. We were approached by the NRC for our phase II trial. We've had really good dialogue ever since phase I started. That process has gone on. That started probably about two months ago, as we geared up to conclude our phase I trial and release

International Trade committee  —so there are certain things there. What we're missing, really, is the manufacturing support. It seems as though all of the manufacturing support is targeted at a facility. They want to go and do a ribbon-cutting. What we need is the backing to go out and buy the raw supplies so

International Trade committee  Thank you very much for the opportunity to join you today. Messenger RNA is the most effective vaccine technology on the planet. The European Union has indicated that it intends to move exclusively to messenger RNA vaccines beginning in 2022. The U.S.A., while not publicly makin

Finance committee  Again, you're referring to a quote from back in January. I have to acknowledge that in the last 30 days the level of communication between Providence and the federal government, particularly the strategic innovation fund, has seen a significant uptick. We have been formally invit

Finance committee  I'm not somebody who likes to watch life in the rear-view mirror. I like to think of what's coming forward. I believe the federal government is learning from the past, is going to seek and take advantage of the opportunity presented to it to have a world-class mRNA vaccine manufa

Finance committee  Candidly, the chance of us producing 50 million doses has passed. That was proposed and the federal government and the provincial governments were made aware of it in January. The Manitoba government took advantage of that opportunity. In order for us to produce the vaccines in

Finance committee  The soonest we can start production in Canada at scale now is no longer in July; it would be in September. We still could produce tens of millions of vaccines this year.

Finance committee  Our term sheet we have with the Manitoba government, and what was proposed across the board in Canada, was $18 Canadian a dose. I'm not ashamed to say that Providence is making a fairly reasonable profit at that price. If there was an opportunity to do something and improve on th